Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)
沙格列汀 2 mg 和 4 mg 对 2 型糖尿病患者血糖控制、血脂谱和心血管疾病风险的影响：一项为期 56 周的随机、双盲、3 期研究（PRESS XII 研究）
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-020-01073-w
Krishnappa, Manjunath; Patil, Kishor; Parmar, Krupi; Trivedi, Purav; Mody, Nirali; Shah, Chintan; Faldu, Khushboo; Maroo, Sanjay; Parmar, Deven
